COGT - Cogent Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
7,871
22,499
Operating Expense
129,734
147,839
75,551
90,070
54,677
Operating Income
-129,734
-147,839
-75,551
-82,199
-32,178
Net Non Operating Interest Income Expense
1,986
3,989
467
144
267
Other Income Expense
2,213
3,609
2,811
7,247
78
Pretax Income
-125,535
-140,241
-72,273
-74,808
-31,833
Net Income Common Stockholders
-125,535
-140,241
-72,273
-179,208
-31,833
Diluted NI Available to Com Stockholders
-125,535
-140,241
-72,273
-179,208
-31,833
Basic EPS
-
-
-1.65
-16.17
-4.18
Diluted EPS
-
-
-1.65
-16.17
-4.18
Basic Average Shares
-
-
43,806
11,081
7,620
Diluted Average Shares
-
-
43,806
11,081
7,620
Total Operating Income as Reported
-129,734
-147,839
-75,551
-82,199
-32,178
Total Expenses
129,734
147,839
75,551
90,070
54,677
Net Income from Continuing & Discontinued Operation
-125,535
-140,241
-72,273
-74,808
-31,833
Normalized Income
-125,535
-140,241
-72,273
-82,301
-31,833
Interest Income
1,986
3,989
467
144
267
Net Interest Income
1,986
3,989
467
144
267
EBIT
-129,734
-147,839
-75,551
-82,199
-32,178
EBITDA
-126,091
-
-
-
-
Reconciled Depreciation
3,643
5,878
147
720
1,293
Net Income from Continuing Operation Net Minority Interest
-125,535
-140,241
-72,273
-74,808
-31,833
Total Unusual Items Excluding Goodwill
0
-
0
7,493
-
Total Unusual Items
0
-
0
7,493
-
Normalized EBITDA
-126,091
-147,839
-75,404
-89,692
-32,178
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more